Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexalin Technology (NXL) Cash & Equivalents (2021 - 2026)

Nexalin Technology has reported Cash & Equivalents over the past 5 years, most recently at $3.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 434.12% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, up 434.12%, while the annual FY2025 figure was $3.1 million, 434.12% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $3.1 million at Nexalin Technology, up from $590075.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $7.9 million in Q3 2022 and troughed at $162743.0 in Q4 2022.
  • A 5-year average of $1.6 million and a median of $590075.0 in 2025 define the central range for Cash & Equivalents.
  • On a YoY basis, Cash & Equivalents climbed as much as 1355.18% in 2023 and fell as far as 95.4% in 2023.
  • Year by year, Cash & Equivalents stood at $661778.0 in 2021, then plummeted by 75.41% to $162743.0 in 2022, then surged by 1355.18% to $2.4 million in 2023, then plummeted by 75.74% to $574485.0 in 2024, then skyrocketed by 434.12% to $3.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for NXL at $3.1 million in Q4 2025, $590075.0 in Q3 2025, and $431320.0 in Q2 2025.